Tradestie Institutional Equity Comparison Engine

BHVN vs SRPT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SRPT counters with relative strength in Valuation. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SRPT at 10.8x Forward P/E and -0.4% operating margin (-4.5% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against SRPT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SRPT
BHVN N/M vs SRPT 10.8x Fwd P/E
Growth & Margin Winner BHVN
Op Margin 0.0% vs -0.4% ยท YoY +0.0% vs -4.5%
Momentum & Technical Winner BHVN
1Y +72.1% vs -15.0% ยท 52W Pos 59% vs 5%
Options & Structure Winner BHVN
CONSOLIDATION (18th %ile IV) vs BREAKDOWN (7th %ile IV)
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.90
+0.62% 1D
Market Cap $2.1B
1M Return +28.99%
1Y Return +72.09%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
SRPT NASDAQ
Sarepta Therapeutics,, Inc. Common Stock
Pharmaceutical Preparations
$15.14
-5.76% 1D
Market Cap $1.7B
1M Return -11.44%
1Y Return -15.02%
Forward P/E 10.8x
Unified AI Score
37.8 / 100 SELL
Tech 32.0 Fund 51.0 Flow 71.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHVN +72.09% SRPT -15.02% Spread: +87.11 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHVN TTM Op. Margin: 0.0% SRPT TTM Op. Margin: -0.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHVN vs SRPT. Trailing 12-month operating profitability (BHVN 0.0% vs SRPT -0.4%) and valuation multiples (BHVN N/M vs SRPT 10.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHVN (6) vs SRPT (3)
Institutional Metric BHVN SRPT Criterion Row Winner
Market Capitalization Scale $2.1B $1.7B Larger Scale BHVN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M 10.8x Lower Multiple SRPT
Revenue Growth (YoY) Growth +0.0% -4.5% Higher Growth BHVN
Operating Margin (TTM) Profitability 0.0% -0.4% Higher Margin BHVN
Net Profit Margin Profitability 0.0% -5.9% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -799.5% -8.1% Higher ROE SRPT
52-Week Range Position Momentum 59% ($8โ€“$18) 5% ($15โ€“$25) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 1.41ฮฒ ยท 111% Vol 1.47ฮฒ ยท 58% Vol Lower Realized Risk SRPT
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 37.8 / 100 (SELL) Higher Composite BHVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHVN vs SRPT Buy Guide
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRPT BREAKDOWN
52d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live SRPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHVN nor SRPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.